Nexplanon Observational Risk Assessment Study (NORA)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2015
At a glance
- Drugs Etonogestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Acronyms NORA
- 06 Jan 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 02 Dec 2013 Planned end date (1 Oct 2017) added as reported by ClinicalTrials.gov.
- 22 Nov 2011 New trial record